Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cochlear ( (AU:COH) ) has shared an announcement.
Cochlear Limited has applied for quotation on the ASX of 86 additional ordinary fully paid shares, to be issued on 29 January 2026 under an employee incentive scheme. The small issuance reflects routine equity-based remuneration rather than a capital-raising, signalling ongoing use of share-based incentives to attract and retain staff without materially impacting the company’s capital structure or shareholder dilution.
The most recent analyst rating on (AU:COH) stock is a Sell with a A$270.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a global medical device company specialising in implantable hearing solutions, including cochlear implants and related technologies, targeting patients with moderate to profound hearing loss and operating primarily in the hearing healthcare sector.
Average Trading Volume: 121,684
Technical Sentiment Signal: Hold
Current Market Cap: A$17.9B
For detailed information about COH stock, go to TipRanks’ Stock Analysis page.